1 Min Read
July 21 (Reuters) - Shenzhen Hepalink Pharmaceutical CO Ltd
* Says it plans to buy Shenzhen Topknow Industry and Development via share issue
Source text in Chinese: bit.ly/2uPpXdG
Further company coverage: (Reporting by Hong Kong newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.